Discovery of olmesartan hexetil: A new potential prodrug of olmesartan
- Authors
- El-Gamal, Mohammed I.; Anbar, Hanan S.; Chung, Hye Jin; Kim, Hyun-Il; Cho, Young-Jin; Lee, Bong Sang; Lee, Sun Ahe; Moon, Ji Yun; Lee, Dong Jin; Kwon, Dow; Choi, Won-Jai; Jeon, Hong-Ryeol; Oh, Chang-Hyun
- Issue Date
- 2013-03-01
- Publisher
- Pergamon Press Ltd.
- Citation
- Bioorganic & Medicinal Chemistry Letters, v.23, no.5, pp.1347 - 1350
- Abstract
- Synthesis of a new ester prodrug of olmesartan, olmesartan hexetil (1), is described. It is in vitro stabilities and in vivo pharmacokinetics (PK) were evaluated. It showed high stability in simulated gastric juice, and was rapidly hydrolyzed to olmesartan in rat liver microsomes and rat plasma in vitro. C-max and AUC(last) for olmesartan were significantly increased in case of hexetil prodrug, compared with olmesartan medoxomil. Olmesartan hexetil is proposed to be an efficient prodrug of olmesartan with markedly increased oral bioavailability. (C) 2013 Elsevier Ltd. All rights reserved.
- Keywords
- II RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME; BIOACTIVATING HYDROLASE; MEDOXOMIL; BLOCKER; RENIN; ACIDS; II RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME; BIOACTIVATING HYDROLASE; MEDOXOMIL; BLOCKER; RENIN; ACIDS; Antihypertensive; Olmesartan medoxomil; Olmesartan hexetil; Prodrug; Ester; Pharmacokinetics
- ISSN
- 0960-894X
- URI
- https://pubs.kist.re.kr/handle/201004/128254
- DOI
- 10.1016/j.bmcl.2012.12.090
- Appears in Collections:
- KIST Article > 2013
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.